Ignite Creation Date:
2025-12-24 @ 11:53 AM
Ignite Modification Date:
2026-01-28 @ 9:38 AM
Study NCT ID:
NCT00893061
Status:
COMPLETED
Last Update Posted:
2024-06-14
First Post:
2009-05-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer
Sponsor:
Centre Oscar Lambret
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | stage IA breast cancer | View |
| None | stage IB breast cancer | View |
| None | stage II breast cancer | View |
| None | stage IIIA breast cancer | View |
| None | stage IIIB breast cancer | View |
| None | stage IIIC breast cancer | View |
| None | estrogen receptor-positive breast cancer | View |
| None | progesterone receptor-positive breast cancer | View |